98
Kevin P Banks, MD Department Radiology San Antonio Military Health System & Health Education Consortium Assistant Professor of Radiology & Nuclear Medicine Uniformed Services University of Health Sciences RENAL SCINTIGRAPHY

Tumor Imaging

  • Upload
    others

  • View
    9

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Tumor Imaging

Kevin P Banks, MD Department Radiology San Antonio Military Health System & Health Education Consortium Assistant Professor of Radiology & Nuclear Medicine Uniformed Services University of Health Sciences

RENAL SCINTIGRAPHY

Page 2: Tumor Imaging

I HAVE NO DISCLOSURES.

Page 3: Tumor Imaging

Learning Objectives

ú Review common types of renal scintigraphic exams and their clinical applications   Review components of dynamic renography exam

interpretation & normal versus abnormal values   Discuss pitfalls in diuretic renography that can

cause false positive results   Review use & interpretation of renal anatomic

scintigraphy   Discuss radionuclide cystography technique and

diagnosis of vesicoureteral reflux

Page 4: Tumor Imaging

GU OBSTRUCTION

IMAGING

Page 5: Tumor Imaging

Indication for Diuretic Renal Scintigraphy

§ Differentiate obstructive vs Non-obstuctive hydronephrosis

Page 6: Tumor Imaging

Obstructive Hydronephrosis

§Congenital stenosis §Stricture §Lithiasis §Tumor

Page 7: Tumor Imaging

Non-Obstructive Hydronephrosis   Congenital dilation   Vesicoureteral reflux (VUR)   Urinary tract infection (UTI)   Non-compliant bladder   Prior obstruction

Page 8: Tumor Imaging

Principles of Diuretic Renography

ÄPhysiologic Conditions: Urine (radiotracer) pools in dilated collecting system either due to reservoir effect or obstruction of outflow

ÄFurosemide (Lasix): Induces increased urine flow ú Dilated non-obstructed system à diuresis

produces rapid washout of activity ú Obstructed system à fixed narrowing prevents

significant increased flow and thus prolongs retention of tracer

Page 9: Tumor Imaging

Protocol/Procedure

q 10 mCi of Tc-99m MAG3 (peds: 100-150 uCi/kg, min 1.0 mCi) [1]

q 40 mg IV Lasix (peds: 1 mg/kg)

q Supine imaging with camera posterior

q Image for 20-30 min following injections of radiotracer & diuretic

q Post-void image

[1] Gelfand MJ, Parisi MT, and Treves ST. Pediatric Radiopharmaceutical Administered Doses: 2010 North American Consensus Guidelines. JNM 2010;52(2):318-322

Page 10: Tumor Imaging

SNM Procedure Guidelines [2]

3 different approaches for time of injection of diuretic furosemide (F) in relation to injection of radiopharmaceutical (Tc-99m MAG3 ):

å 20 min after radiopharmaceutical (F+20) ù or later when dilated system is filled

ç 15 min before the injection of radiopharmaceutical (F-15)

é Simultaneous injection of Tc-99m MAG3 & diuretic (F+0) [3,4]

Protocol/Procedure

[2] Shulkin BL, Mandell GA, Cooper JA. Procedure guideline for diuretic renography in children 3.0. JNMT 2008;36(3):162-168 [3] Sfakianakis GN et al: A renal protocol for all indications: MAG3 with simultaneous injection of furosemide (MAG3-F0): a fifteen year experience. J Nucl Med 2007:48(suppl 2): 125P. [4] Turkolmez S, Atasever T, Turkolmez K, Gogus O. Comparison of three different diuretic renal scintigraphy protocols in patients with dilated upper urinary tracts. Clin Nucl Med 2004:29(3):154-160.

SFU

Page 11: Tumor Imaging

Interpretation

§ Flow = prompt & symmetric

§ Differential Function = 45-55% each § Time to peak activity = 3-5 minutes

§ 20-minute-to-peak count ratio = < 0.3 (30%)

§ Half-time excretion = < 10 minutes is NORMAL

Page 12: Tumor Imaging

40 yo F with Hx of Kidney Stones and R Hydronephorsis

Page 13: Tumor Imaging

F+O Protocol (Lasix administered at time of radiotracer)

FLOW PHASE

NORMAL RENAL FLOW • RENAL FLOW IS PROMPT à1-3 SEC AFTER AORTA • RENAL FLOW IS SYMMETRIC

• GOOD TIGHT BOLUS

Page 14: Tumor Imaging

F+O Protocol (Lasix administered at time of radiotracer)

FLOW PHASE

AORTA FIRST VISIBLE

RENAL FLOW APPEARS W/IN 2 sec

Page 15: Tumor Imaging

F+O Protocol (Lasix administered at time of radiotracer)

NORMAL RENAL FUNCTION • PEAK PARENCHYMAL ACTIVITY <3-5 MIN • TIME TO PEAK AND INTENSITY ARE SYMMETRIC

• <=30% RETENTION 20 MIN AFTER PEAK NORMAL RENAL EXCRETION • 50% COLLECTING SYSTEM ACTIVITY GONE BY 10 MIN AFTER COLLECTING SYSTEM PEAK

FUNCTION & EXCRETION

PHASES

Page 16: Tumor Imaging

F+O Protocol (Lasix administered at time of radiotracer) F

UNCTION & EXCRETION

PHASES

COLLECTING SYSTEM ACTIVITY APPEARS

Page 17: Tumor Imaging

RENOGRAM

Page 18: Tumor Imaging

5 MIN 10 MIN 15 MIN 20 MIN

COUNTS

VASCULAR PHASE ~ 30-60 s

FUNCTIONAL PHASE ~ 1-5 m

EXCRETION PHASE

RENOGRAM

T ½ EXCRETION < 10 m DIFFERENTIAL

FUNCTION 2-3 m 45–55 %

T Peak < 3-5 m

25 MIN

T Peak-to-20min < = 30 %

Page 19: Tumor Imaging

RENOGRAM

Page 20: Tumor Imaging

RENOGRAM

Page 21: Tumor Imaging

RENOGRAM

Page 22: Tumor Imaging

RENOGRAM

Page 23: Tumor Imaging
Page 24: Tumor Imaging
Page 25: Tumor Imaging

1 Month Later...

Page 26: Tumor Imaging

F+20 Protocol Lasix administered after initial imaging

50 yo M s/p Pyeloplasty (No Prior Imaging)

Pre-lasix

T = 1-20min

Page 27: Tumor Imaging

Post-lasix

T = 21-40min

Page 28: Tumor Imaging

PRE-LASIX

Page 29: Tumor Imaging

POST-LASIX

Page 30: Tumor Imaging

Interpretation

§ Flow = prompt & symmetric

§ Differential Function = 45-55% each § Time to peak activity = 3-5 minutes

§ 20-minute-to-peak count ratio = < 0.3 (30%)

§ Half-time excretion = < 10 minutes is NORMAL

Page 31: Tumor Imaging

Classic Interpretation

§ Half-time excretion = < 10 minutes is NORMAL § Half-time excretion >10 minutes but <20 minutes is INDETERMINATE

§ Half-time excretion > 20 minutes is OBSTRUCTED

15-20%

Page 32: Tumor Imaging

Interpretation

§ Half-time excretion > 10 minutes is DELAYED § Half-time excretion >10 minutes but <15 ú Unlikely clinically significant difference from patients

with T-1/2 =< 10 minutes

§ Half-time excretion > 15 minutes but < 20 ú Likely unobstructed, but evaluated the same as cases

with T-1/2 > = 20 minutes

Page 33: Tumor Imaging

Interpretation

§ Half-time excretion > 20 minutes is ABNORMAL Starting point for diagnosing OBSTRUCTION èLook at shape of curve èLook at post void collecting system activity èEvaluate cortical clearance (aka tissue transit time)

Page 34: Tumor Imaging

Interpretation

§ Look at shape of curve èINCREASING or PLATEAU ✓ OBSTRUCTED

F = 0

Time Activity Curve

24 min

Page 35: Tumor Imaging

26 yo M with s/p Ureteral Implant

Page 36: Tumor Imaging

F+O Protocol Lasix administered at time of radiotracer

T = 1-20min

Page 37: Tumor Imaging
Page 38: Tumor Imaging

Post Void Image

Page 39: Tumor Imaging

Interpretation

§ Look at shape of curve èINCREASING or PLATEAU ✓ OBSTRUCTED

F = 0

Time Activity Curve

24 min

Page 40: Tumor Imaging

Interpretation

§ Look at shape of curve èDECREASES < 50% ✓ QUESTIONABLE

F = 0

Time Activity Curve

20 min

50 % 50 %

Page 41: Tumor Imaging

Interpretation

§ Half-time excretion > 20 minutes is ABNORMAL Starting point for diagnosing OBSTRUCTION èLook at shape of curve èLook at post void collecting system activity èEvaluate cortical clearance (aka tissue transit time)

Sfiakianakis GN, et al. A Renal Protocol for All Ages and All Indications: MAG3 with Simultaneous Injection of Furosemide: A 17-year Experience. Semin Nuc Med 2009.

Page 42: Tumor Imaging

50 yo F with Hx of Colorectal Cancer and New R Pelvicaliectasis

Page 43: Tumor Imaging

F+O Protocol Lasix administered at time of radiotracer

T = 1-20min

Page 44: Tumor Imaging
Page 45: Tumor Imaging
Page 46: Tumor Imaging

Post Void Image

Page 47: Tumor Imaging
Page 48: Tumor Imaging
Page 49: Tumor Imaging
Page 50: Tumor Imaging

F+O Protocol Lasix administered at time of radiotracer

T = 1-20min

RIGHT KIDNEY SHOWS NORMAL TISSUE TRANSIT / CORTICAL FUNCTION

Page 51: Tumor Imaging

DELAYED COLLECTING SYSTEM EMPTYING WITHOUT PARENCHYMAL DYSFUNCTION

Page 52: Tumor Imaging

46 yo M with Retroperitoneal Fibrosis

T = 2 min T = 5 min T = 20 min

Page 53: Tumor Imaging

46 yo M with Retroperitoneal Fibrosis

T-1/2 >> 20 min

Page 54: Tumor Imaging

46 yo M with Retroperitoneal Fibrosis

T-1/2 >> 20 min

Page 55: Tumor Imaging

46 yo M with Retroperitoneal Fibrosis

T = 2 min T = 5 min

POST VOID

ABNORMAL COLLECTING SYSTEM RETENTION

Page 56: Tumor Imaging

46 yo M with Retroperitoneal Fibrosis

KIDNEYS SHOW NORMAL TISSUE TRANSIT / CORTICAL FUNCTION

Page 57: Tumor Imaging

46 yo M with Retroperitoneal Fibrosis

KIDNEYS SHOW NORMAL TISSUE TRANSIT / CORTICAL FUNCTION

DELAYED COLLECTING SYSTEM EMPTYING WITHOUT PARENCHYMAL DYSFUNCTION

Page 58: Tumor Imaging

6 yo M with R Duplicated CS

POST VOID

Page 59: Tumor Imaging

R UPPER R LOWER

Page 60: Tumor Imaging

Diuretic Renography

Pitfalls

ú Poor renal function → Diminished diuretic response

ú Poor hydration → Poor diuretic response

ú Over-compliant renal pelvis → Reservoir effect – very large hydronephrotic volume

ú Difficulty voiding → Backpressure blunts diuretic response

Page 61: Tumor Imaging

61 yo M with L Hydroureter

Page 62: Tumor Imaging
Page 63: Tumor Imaging
Page 64: Tumor Imaging

Post Void Image

Page 65: Tumor Imaging

Diuretic Renography § Pitfalls

ú Poor renal function   Need to be able to excrete adequate

radiotracer and respond to diuretic   GFR should be > 15 mL/min

  Considered increased dose of Lasix (80-150mg) for low GFR or patients chronically on Lasix

ú Poor hydration   Hold diuretics on day of exam   Oral hydration 750-1000cc 30 min prior

Page 66: Tumor Imaging

51 yo F with Ovarian Cancer and Mild Bilateral Hydronephrosis

Page 67: Tumor Imaging
Page 68: Tumor Imaging

T=1 min

T=10 min

T=20 min

Page 69: Tumor Imaging

Diuretic Renography

§ Pitfalls

ú Noncompliant bladder → Backpressure blunts diuretic response ­ Have patients void before start of study ­ Recommend use of Foley catheter for

patients with difficultly voiding (neurogenic bladder, low-bladder capacity, +/- young children)

Page 70: Tumor Imaging

Courtesy of Dr. Patrick Colletti Director Nuclear Nuclear Fellowship University of Southern California

Page 71: Tumor Imaging

Courtesy of Dr. Patrick Colletti Director Nuclear Nuclear Fellowship University of Southern California

Page 72: Tumor Imaging

Courtesy of Dr. Patrick Colletti Director Nuclear Nuclear Fellowship University of Southern California

LEFT VUR

Page 73: Tumor Imaging

GU INFECTION AND REFLUX

Page 74: Tumor Imaging

AAP and AAFP

“Bottom-up” approach

only 61% adherence

Lim R. Vesicoureteral Reflux and Urinary Tract Infection: Evolving Practices and Current Controversies in Pediatric Imaging. AJR 2009;192:1197-1208

Page 75: Tumor Imaging

European Society of Pediatric Radiology

“Top-down” approach

DMSA emphasis

Lim R. Vesicoureteral Reflux and Urinary Tract Infection: Evolving Practices and Current Controversies in Pediatric Imaging. AJR 2009;192:1197-1208

Page 76: Tumor Imaging

Anatomic Imaging

DMSA (or glucoheptonate) ú Edema/Inflammation ú Scar ú Space occupying lesions ú Functioning pseudotumors (columns of

Bertin) ú Horseshoe kidney

MUCH MORE SENSITIVE THAN US FOR PYELONEPHRITIS AND SCARRING

Page 77: Tumor Imaging

Protocol/Procedure

q 50 uCi/kg of Tc-99m DMSA (min 300 uCi) [5]

q Supine imaging with camera posterior

q Images acquired 2-hr after injection

q Planar parallel posterior and posterior oblique high-resolution images

q SPECT and pin-hole more sensitive, but role not definitively defined

[5] Mandell GA, et. Procedure guideline for renal cortical scintigraphy in children 3.0 in SNM Procedure Guideline Manual

Page 78: Tumor Imaging

Acute Pyelonephritis

Three common patterns:

ú Focal cortical defects

ú Multifocal cortical defects

ú Diffusely decreased activity

INDISTINGUISHABLE FROM SCARRING

Page 79: Tumor Imaging

4 yo F with UTI

POSTERIOR STATICS

CORONAL SPECT

FOCAL CORTICAL DEFECT

Page 80: Tumor Imaging

4 yo F with VUR and UTI

POSTERIOR STATICS CORONAL SPECT

MULTIFOCAL CORTICAL DEFECTS

Page 81: Tumor Imaging

8 yo F with VUR and recurrent UTIs

DIFFUSE DECREASED ACTIVITY

Page 82: Tumor Imaging

8 yo F with VUR and recurrent UTIs

Page 83: Tumor Imaging

8 yo F with horseshoe kidney, recurrent UTIs, and HTN

NO ACTIVITY BETWEEN KIDNEYS à FIBROUS ISTHMUS

Page 84: Tumor Imaging

Vesicoureteral Reflux Imaging

RADIONUCLIDE CYSTOGRAPHY (RNC) §More sensitive than contrast cystography ú Detects as low as 1mL of reflux

§Much less gonadal radiation exposure ú 0.5-1 mCi pertechnetate, DTPA, or sulfur colloid ú 1/10th fluoroscopy

BUT… §No international standard for grading §Poor anatomic detail

Page 85: Tumor Imaging

Radionuclide Cystography

RNC versus VCUG?

§ VCUG as the initial test ú Severity of VUR ú Anatomic abnormalities

§ RNC for follow up ú Document resolution ú After surgery ú Screening siblings

Page 86: Tumor Imaging

Radionuclide Cystography

§ Minimal ú Reflux confined to ureter

§ Moderate ú Pelvicalyceal system

§ Severe ú Into the pelvicalyceal system with dilated

intrarenal collecting system and/or dilated tortuous ureter

Page 87: Tumor Imaging

3 yo female with UTI

POST VOID

START

VOIDING STARTS

Page 88: Tumor Imaging

3 yo female with UTI

POST VOID

LEFT MILD VUR

Page 89: Tumor Imaging

3 yo female with UTI

LEFT MODERATE VUR

**PATIENT MOTION DURING EXAM**

VUR APPEARS AS PATIENT BEGINS TO VOID - - POINT OF MAX INTRAVESICULAR PRESSURE

Page 90: Tumor Imaging

2 yo female with h/o UTI & dysfunctional voiding

START

VOIDING STARTS

Page 91: Tumor Imaging

2 yo female with h/o UTI & dysfunctional voiding

BILATERAL MODERATE VUR

Page 92: Tumor Imaging

4 yo female with h/o VUR

RIGHT SEVERE

VUR

Page 93: Tumor Imaging

4 yo female with h/o VUR

NEGATIVE VCUG

Page 95: Tumor Imaging

REVIEW

Diuretic Renography

• Differentiates dilated (patulous) non-obstructed system from true obstruction • F-15 vs F+0 vs F+20 generally equivalent • T1/2 excretion <=10 min normal >20 min abnormal • FP include: à poor renal function à severely dilated collecting system à dehydration à back-pressure effect in setting of difficulty voiding

Page 96: Tumor Imaging

REVIEW

Cortical Scintigraphy

• More sensitive than US for pyelonephritis • Solitary or multiple defects versus diffuse decreased activity • Cannot reliably differentiate acute pyelonephritis versus scar by imaging features • Pin-hole and SPECT more sensitive than planar, but significance of findings not seen on planar is questionable

Page 97: Tumor Imaging

REVIEW

Radionuclide Cystography

• More sensitive than VCUG • Less gonadal radiation than VCUG • Poor anatomic detail • No standardize international grading

• Mild = reflux to ureter • Moderate = reflux to renal pelvis • Severe = reflux to pelvis with pelvic/ureteral tortuosity

• Likely ideal for follow-up/post-intervention & screening siblings

Page 98: Tumor Imaging

THANK YOU

[email protected]